Molecular Pharmacology of the Sodium Channel Mutation D1790G Linked to the Long-QT Syndrome
- 22 August 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (8) , 921-925
- https://doi.org/10.1161/01.cir.102.8.921
Abstract
Background—Multiple mutations of SCN5A, the gene that encodes the human Na+ channel α-subunit, are linked to 1 form of the congenital long-QT syndrome (LQT-3). D1790G (DG), an LQT-3 mutation of the...Keywords
This publication has 16 references indexed in Scilit:
- Gene-Specific Therapy for Long QT Syndrome.Annals of Noninvasive Electrocardiology, 1997
- Pharmacological targeting of long QT mutant sodium channels.Journal of Clinical Investigation, 1997
- Molecular properties of sodium and calcium channelsJournal of Bioenergetics and Biomembranes, 1996
- Molecular mechanism for an inherited cardiac arrhythmiaNature, 1995
- SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndromeCell, 1995
- Lidocaine block of cardiac sodium channels.The Journal of general physiology, 1983
- Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patchesPflügers Archiv - European Journal of Physiology, 1981
- Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channelsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1977
- Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.The Journal of general physiology, 1977
- The long Q-T syndromeAmerican Heart Journal, 1975